Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 14, 2019 Off

Niemann-Pick Disease Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Niemann-Pick Disease Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Niemann-Pick Disease…

June 14, 2019 Off

Spinocerebellar Ataxia Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Spinocerebellar Ataxia Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Spinocerebellar Ataxia…

June 14, 2019 Off

Progressive Supranuclear Palsy Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Progressive Supranuclear Palsy Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Progressive…

June 14, 2019 Off

Hurler’s Syndrome Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hurler’s Syndrome Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Hurler’s Syndrome…

June 14, 2019 Off

Dravet Syndrome Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Dravet Syndrome Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Dravet Syndrome…

June 14, 2019 Off

First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, PUblished by Amazentis and Researchers From the EPFL and SIB

By BusinessWire

Breakthrough translational science of dietary supplementation with Urolithin A, a pomegranate metabolite, on mitochondrial and cellular health in humans published…

June 14, 2019 Off

22nd Century Group Appoints Michael J. Zercher as Chief Operating Officer

By BusinessWire

WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm…

June 14, 2019 Off

Kaposi’s Sarcoma Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Kaposi’s Sarcoma Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Kaposi’s Sarcoma…

June 14, 2019 Off

Optic Neuromyelitis Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Optic Neuromyelitis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Optic Neuromyelitis…

June 14, 2019 Off

Genital Herpes Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Genital Herpes Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Genital Herpes…

Posts pagination

Previous 1 … 3,080 3,081 3,082 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine